Below are the financial statements of Viking Therapeutics, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in thousands of USD | 2024 as of 2024-12-31 | 2023 as of 2023-12-31 |
|---|---|---|
| Assets | — | — |
| Current assets | — | — |
| Cash and cash equivalents | 26,676a | 55,516a |
| Short-term investments - available-for-sale | 875,936a | 306,563a |
| Prepaid clinical trial and preclinical study costs | 3,476a | 2,624a |
| Prepaid expenses and other current assets | 1,128a | 2,522a |
| Total current assets | 907,216a | 367,225a |
| Right-of-use assets | 1,003a | 1,126a |
| Deferred financing costs | 56a | 106a |
| Deposits | 46a | 33a |
| Total assets | 908,321a | 368,490a |
| Liabilities and stockholders’ equity | — | — |
| Current liabilities | — | — |
| Accounts payable | 9,813a | 7,512a |
| Other accrued liabilities | 17,111a | 11,299a |
| Lease liability, current | 489a | 324a |
| Total current liabilities | 27,413a | 19,135a |
| Lease liability, net of current portion | 630a | 936a |
| Total long-term liabilities | 630a | 936a |
| Total liabilities | 28,043a | 20,071a |
| Stockholders’ equity | — | — |
| Preferred stock | 0a | 0a |
| Common stock | 1a | 1a |
| Treasury stock at cost | 0a | -6,795a |
| Additional paid-in capital | 1,368,972a | 733,546a |
| Accumulated deficit | -487,907a | -377,944a |
| Accumulated other comprehensive loss | -788a | -389a |
| Total stockholders’ equity | 880,278a | 348,419a |
| Total liabilities and stockholders’ equity | 908,321a | 368,490a |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.